SPCC663.14c Antibody

What is the SPCC663.14c antibody and what is its target?

The SPCC663.14c antibody is a polyclonal antibody raised in rabbits against the recombinant Schizosaccharomyces pombe (strain 972/ATCC 24843, commonly known as fission yeast) SPCC663.14c protein. This antibody targets the protein encoded by the SPCC663.14c gene locus in S. pombe, which has the UniProt accession number O74520 . When designing experiments with this antibody, researchers should consider that as a polyclonal preparation, it contains multiple antibody species recognizing different epitopes of the target protein, which can provide robust detection but may also introduce variability between batches.

What applications has the SPCC663.14c antibody been validated for?

The SPCC663.14c antibody has been validated primarily for Western blotting (WB) and enzyme-linked immunosorbent assay (ELISA) applications . These validations ensure the antibody can specifically identify its target in these particular experimental contexts. Researchers should note that antibody validation in multiple applications serves as a cross-check for specificity and provides additional experimental confidence . When planning experiments, it's advisable to conduct preliminary validation tests in your specific experimental system, particularly if using applications beyond those officially validated.

What are the recommended storage conditions for maintaining SPCC663.14c antibody activity?

For optimal maintenance of antibody activity, store the SPCC663.14c antibody at -20°C or -80°C upon receipt. Critical to preserving antibody function is avoiding repeated freeze-thaw cycles, which can lead to protein denaturation and consequent loss of binding capacity . The antibody is supplied in a protective storage buffer containing 0.03% Proclin 300 preservative, 50% glycerol, and 0.01M PBS at pH 7.4, which helps maintain stability during storage . For routine use, preparing small working aliquots is recommended to minimize freeze-thaw damage while maintaining a consistent stock concentration.

How should I validate the specificity of the SPCC663.14c antibody in my experimental system?

Thorough validation of antibody specificity is critical for ensuring experimental reproducibility. For the SPCC663.14c antibody, implement a multi-faceted approach:

• Positive and negative controls: Use wild-type S. pombe extracts as positive controls, and if possible, SPCC663.14c knockout strains as negative controls.

• Molecular weight verification: Confirm that the detected band in Western blots appears at the expected molecular weight for the SPCC663.14c protein.

• Cross-reactivity assessment: Test the antibody against closely related proteins or in non-target species to evaluate potential cross-reactivity.

• Immunoprecipitation followed by mass spectrometry: For definitive validation, perform immunoprecipitation with the antibody followed by mass spectrometric analysis of the precipitated proteins .

Inadequate antibody validation can lead to misleading results, as demonstrated in studies of other antibodies where commercially available reagents failed specificity tests despite manufacturer claims . Researchers have shown that even antibodies marketed as phospho-specific may recognize multiple phosphoproteins, emphasizing the importance of rigorous validation .

What are the recommended dilutions and conditions for Western blotting with the SPCC663.14c antibody?

For Western blotting applications, begin with a dilution range of 1:500 to 1:2000 of the SPCC663.14c antibody. Optimal conditions typically include:

• Sample preparation: Lyse S. pombe cells using a buffer containing protease inhibitors and, if studying phosphorylation states, phosphatase inhibitors.

• Blocking buffer: Use 5% non-fat milk or 3-5% BSA in TBST (TBS with 0.1% Tween-20).

• Primary antibody incubation: Incubate membranes with diluted antibody overnight at 4°C or for 2 hours at room temperature.

• Secondary antibody: Use an anti-rabbit IgG conjugated with HRP or a fluorescent tag at a dilution of 1:5000 to 1:10000.

• Signal detection optimization: For chemiluminescent detection, exposure times should be optimized to avoid saturation.

When optimizing Western blot conditions, it's essential to test multiple concentrations of both primary and secondary antibodies to identify the combination that yields the highest signal-to-noise ratio . Comparing results with existing literature on SPCC663.14c protein expression can help validate your findings.

What controls should be included when using the SPCC663.14c antibody in immunofluorescence experiments?

While the SPCC663.14c antibody hasn't been explicitly validated for immunofluorescence, researchers attempting this application should include the following controls:

• Primary antibody omission: Include samples where only the secondary antibody is applied to assess non-specific binding.

• Peptide competition: Pre-incubate the antibody with excess immunizing peptide to verify signal specificity.

• Genetic controls: When possible, include SPCC663.14c knockout or knockdown cells as negative controls.

• Subcellular localization verification: Compare observed localization patterns with published data or predictions for the SPCC663.14c protein.

Researchers should note that validation in multiple applications, as demonstrated with other antibodies like Tubulin β3 (clone TUJ1), provides increased confidence in antibody specificity across experimental systems . For unvalidated applications, preliminary experiments should establish the antibody's performance characteristics before proceeding with full studies.

How can the SPCC663.14c antibody be used to study protein-protein interactions in S. pombe?

The SPCC663.14c antibody can be employed in several advanced techniques to investigate protein-protein interactions:

• Co-immunoprecipitation (Co-IP): Use the antibody to pull down SPCC663.14c protein complexes from S. pombe lysates. This approach can identify native interaction partners under physiological conditions.

• Proximity-dependent biotin identification (BioID): While not directly using the antibody, validation of BioID results often requires Western blotting with specific antibodies like SPCC663.14c.

• Chromatin immunoprecipitation (ChIP): If SPCC663.14c has DNA-binding properties or associates with chromatin, the antibody can be used in ChIP experiments to identify DNA binding sites.

When designing Co-IP experiments, it's crucial to optimize lysis conditions to preserve native protein complexes. Typically, non-ionic detergents like NP-40 or Triton X-100 at concentrations of 0.1-1% provide sufficient solubilization while maintaining many protein-protein interactions. The specificity of interaction results should be verified using controls such as IgG immunoprecipitation and validation in SPCC663.14c-depleted cells .

What approaches can address potential cross-reactivity issues with the SPCC663.14c antibody?

When confronting potential cross-reactivity issues with the SPCC663.14c antibody, consider these advanced troubleshooting approaches:

• Pre-adsorption testing: Pre-incubate the antibody with purified recombinant proteins similar to SPCC663.14c to identify and mitigate cross-reactivity.

• Two-dimensional Western blotting: Separate proteins by both isoelectric point and molecular weight to better discriminate between specific signals and cross-reactive species.

• CRISPR-Cas9 knockout validation: Generate SPCC663.14c knockout cells as definitive negative controls to identify any non-specific signals.

• Parallel antibody comparison: Test multiple antibodies targeting different epitopes of SPCC663.14c to confirm signal consistency.

Recent studies examining antibody specificity have shown that even commercially validated antibodies may exhibit unexpected cross-reactivity . For example, the sc-33040-R antibody against phosphorylated ErbB4 was found to cross-react with other phosphorylated proteins including EGFR and PDGF receptor, despite being marketed as specific . This highlights the importance of rigorous validation beyond manufacturer testing.

How can post-translational modifications of the SPCC663.14c protein be studied using this antibody?

Investigating post-translational modifications (PTMs) of SPCC663.14c requires sophisticated approaches:

• Phosphorylation studies: Combine the SPCC663.14c antibody with phospho-specific antibodies or phosphatase treatments to determine phosphorylation status.

• PTM-specific immunoprecipitation: Use the SPCC663.14c antibody to immunoprecipitate the protein, followed by Western blotting with PTM-specific antibodies (anti-phospho, anti-ubiquitin, etc.).

• Mass spectrometry analysis: Immunoprecipitate SPCC663.14c using the antibody, then perform mass spectrometry to identify and map various PTMs.

When studying phosphorylation, it's essential to include appropriate controls as demonstrated in studies of other phospho-specific antibodies. For example, researchers investigating ErbB4 phosphorylation found that antibodies must be validated against both phosphorylated and unphosphorylated forms of the target protein as well as other phosphoproteins to ensure specificity . Similar principles apply when studying other PTMs of SPCC663.14c.

What steps should I take if I observe weak or no signal when using the SPCC663.14c antibody?

When encountering weak or absent signals with the SPCC663.14c antibody, implement this systematic troubleshooting protocol:

• Antibody activity verification: Test the antibody using a positive control lysate from wild-type S. pombe cells known to express SPCC663.14c.

• Protein extraction optimization:

  • Ensure complete cell lysis using mechanical disruption methods appropriate for S. pombe's rigid cell wall

  • Include protease inhibitors in all buffers to prevent protein degradation

  • Try different lysis buffers (RIPA, NP-40, etc.) to optimize protein extraction

• Detection sensitivity enhancement:

  • Increase antibody concentration (try 2-5× higher concentration)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use more sensitive detection reagents (e.g., high-sensitivity ECL substrates)

  • Increase protein loading (50-100 μg total protein)

• Epitope accessibility improvement: If using fixed samples, test different fixation methods or include an antigen retrieval step, as some epitopes may be masked during sample preparation.

Protein expression levels can vary significantly with growth conditions, so consider testing cells harvested at different growth phases or after specific treatments that might induce SPCC663.14c expression .

How can I minimize background when using SPCC663.14c antibody in Western blotting?

High background is a common challenge when working with polyclonal antibodies like SPCC663.14c. Implement these strategies to improve signal-to-noise ratio:

• Blocking optimization:

  • Test different blocking agents (BSA, non-fat milk, commercial blockers)

  • Increase blocking time (2-3 hours at room temperature or overnight at 4°C)

  • Add 0.05-0.1% Tween-20 to blocking buffer to reduce non-specific binding

• Washing protocol enhancement:

  • Increase wash duration (5-10 minutes per wash)

  • Perform additional wash steps (5-6 washes instead of 3)

  • Use fresh wash buffer with adequate detergent concentration

• Antibody dilution optimization:

  • Prepare antibody in fresh blocking buffer

  • Test a range of antibody dilutions to identify optimal concentration

  • Consider adding 0.05% sodium azide to antibody solution for extended incubations

• Secondary antibody considerations:

  • Ensure secondary antibody is highly cross-adsorbed to prevent species cross-reactivity

  • Use secondary antibody at higher dilutions (1:10,000-1:20,000)

Antibody validation studies have shown that optimizing these parameters can significantly improve specificity and reduce background, as demonstrated in multiple antibody characterization studies .

What are the best approaches for quantifying SPCC663.14c protein levels in diverse experimental conditions?

For accurate quantification of SPCC663.14c protein levels across experimental conditions, implement these methodological approaches:

• Western blot quantification:

  • Include a dilution series of recombinant SPCC663.14c protein to create a standard curve

  • Use digital image analysis software with background subtraction capabilities

  • Normalize target protein signals to validated loading controls (e.g., actin, GAPDH)

  • Perform at least three biological replicates for statistical validity

• ELISA-based quantification:

  • Develop a sandwich ELISA using the SPCC663.14c antibody as capture or detection antibody

  • Create standard curves using purified recombinant protein

  • Validate assay linearity, sensitivity, and reproducibility before experimental application

• Mass spectrometry validation:

  • Use targeted mass spectrometry (MS) approaches like Selected Reaction Monitoring (SRM) to validate antibody-based quantification

  • Implement isotope-labeled standards for absolute quantification

When comparing protein levels between conditions, statistical analysis should account for both technical and biological variation. Consider using analysis of variance (ANOVA) with appropriate post-hoc tests for multi-condition comparisons rather than multiple t-tests to maintain appropriate statistical power .

How can the SPCC663.14c antibody be adapted for high-throughput screening applications?

Adapting the SPCC663.14c antibody for high-throughput screening requires strategic modifications to standard protocols:

• Automated Western blotting:

  • Implement capillary-based Western systems (e.g., ProteinSimple Wes) for higher throughput

  • Optimize antibody concentration specifically for automated systems

  • Develop standardized lysate preparation methods suitable for large sample sets

• Microarray and reverse phase protein array (RPPA) applications:

  • Validate antibody specificity in array format before screening

  • Develop spotting protocols optimized for S. pombe lysates

  • Establish rigorous normalization procedures using multiple housekeeping proteins

• High-content imaging:

  • Adapt the antibody for immunofluorescence in multi-well format

  • Implement automated image acquisition and analysis algorithms

  • Include appropriate controls in each plate to account for staining variability

When developing these high-throughput applications, researchers should test the antibody's performance characteristics at scale before proceeding with full screens. Validation studies similar to those conducted for other research antibodies should confirm that sensitivity and specificity are maintained in high-throughput formats .

What considerations are important when using the SPCC663.14c antibody in developmental or stress-response studies?

When applying the SPCC663.14c antibody to developmental biology or stress-response research in S. pombe, consider these specialized approaches:

• Developmental timing experiments:

  • Synchronize cell populations to examine SPCC663.14c expression across the cell cycle

  • Develop sampling protocols that account for rapid changes in protein levels

  • Use time-course experiments with appropriate temporal resolution

• Stress-response studies:

  • Validate antibody performance under stress conditions that might alter protein structure or PTMs

  • Include appropriate stress-responsive control proteins to validate experimental systems

  • Consider how stress might alter epitope accessibility or protein localization

• Comparative analysis across conditions:

  • Implement standardized quantification methods that work across diverse experimental conditions

  • Include shared controls across all experimental sets for valid comparisons

  • Consider developing internal standard controls (e.g., spiked-in reference proteins)

Research with other antibodies has demonstrated that protein epitopes can be significantly altered during stress conditions or developmental transitions, potentially affecting antibody recognition. Validation experiments should verify that the SPCC663.14c antibody maintains specificity under each experimental condition .

How can I combine the SPCC663.14c antibody with genetic manipulation techniques for comprehensive functional studies?

Integrating antibody-based detection with genetic approaches provides powerful insights into SPCC663.14c function:

• CRISPR-Cas9 gene editing integration:

  • Generate tagged SPCC663.14c variants to compare antibody detection with tag-based detection

  • Create domain-specific mutants to map antibody epitopes and functional domains

  • Develop inducible expression systems to study protein dynamics

• RNAi knockdown correlation:

  • Use the antibody to quantify knockdown efficiency at the protein level

  • Correlate protein reduction with phenotypic outcomes

  • Identify potential compensatory mechanisms by examining related proteins

• Heterologous expression systems:

  • Express SPCC663.14c in different cellular backgrounds to study context-dependent functions

  • Use the antibody to confirm expression levels across diverse systems

  • Identify potential interacting partners unique to specific cellular contexts

When implementing these integrated approaches, researchers should validate that genetic manipulations don't alter epitope recognition by the antibody. For example, studies of phospho-specific antibodies have shown that mutations near phosphorylation sites can significantly impact antibody binding even when the phosphorylation site itself is preserved .

What are the best practices for combining SPCC663.14c antibody with proteomics approaches?

To effectively integrate the SPCC663.14c antibody with proteomics workflows:

• Immunoprecipitation-mass spectrometry (IP-MS):

  • Optimize IP conditions to maximize target protein recovery while minimizing non-specific binding

  • Include appropriate controls (IgG IP, knockdown samples) to identify truly specific interactors

  • Consider crosslinking approaches to capture transient interactions

• Antibody-based protein complex purification:

  • Develop gentle lysis conditions that preserve native protein complexes

  • Validate complex integrity using orthogonal techniques (e.g., size exclusion chromatography)

  • Consider tandem affinity purification approaches for increased specificity

• Validation of proteomics findings:

  • Use the antibody to confirm key MS-identified interactions via co-IP

  • Develop quantitative Western blot protocols to validate abundance changes identified by MS

  • Implement targeted proteomics approaches for focused validation of specific modifications

When designing these experiments, it's crucial to consider that antibody performance may vary between applications. For example, an antibody that works well for Western blotting might not be optimal for immunoprecipitation due to differences in epitope accessibility in native versus denatured conditions .

How does the polyclonal SPCC663.14c antibody compare with potential monoclonal alternatives for different research applications?

Understanding the comparative advantages of polyclonal versus monoclonal approaches for SPCC663.14c detection:

When selecting between polyclonal and monoclonal approaches, consider your specific experimental requirements. For detection of low-abundance proteins or applications requiring high sensitivity, the polyclonal SPCC663.14c antibody may be advantageous. For applications requiring exceptional specificity or long-term consistency, development of monoclonal alternatives might be warranted .

What methodological alternatives should be considered if antibody-based detection of SPCC663.14c proves challenging?

When antibody-based detection presents limitations, consider these alternative approaches:

• Genetic tagging strategies:

  • C-terminal or N-terminal fusion with epitope tags (FLAG, HA, V5)

  • Integration of fluorescent protein tags for direct visualization

  • Split-tag complementation systems for interaction studies

• Targeted mass spectrometry approaches:

  • Selected/Multiple Reaction Monitoring (SRM/MRM) for targeted protein quantification

  • Parallel Reaction Monitoring (PRM) for improved selectivity

  • Development of synthetic peptide standards for absolute quantification

• Proximity labeling methods:

  • BioID or TurboID fusion proteins to identify proximal proteins

  • APEX2-based proximity labeling for subcellular localization studies

  • Split-BioID systems for studying conditional interactions

• Functional reporter systems:

  • Transcriptional reporters to monitor gene expression

  • Activity-based sensors if SPCC663.14c has enzymatic activity

  • Protein complementation assays for interaction studies

These approaches can complement or replace antibody-based methods when specificity or sensitivity issues arise. As with antibody methods, each alternative approach requires appropriate controls and validation to ensure reliable results .

How might the SPCC663.14c antibody be applied in emerging single-cell analysis techniques?

Adapting the SPCC663.14c antibody for single-cell research applications:

• Single-cell Western blotting:

  • Optimize antibody dilution for microfluidic-based single-cell Western platforms

  • Validate detection sensitivity at protein quantities relevant to single cells

  • Develop multiplexing strategies with other antibodies for pathway analysis

• Mass cytometry (CyTOF) applications:

  • Metal-conjugate the antibody for CyTOF analysis of S. pombe populations

  • Validate specificity and sensitivity after metal labeling

  • Develop compatible cell preparation protocols for S. pombe

• Imaging mass cytometry or Multiplexed Ion Beam Imaging (MIBI):

  • Optimize the antibody for tissue section staining if studying SPCC663.14c in complex samples

  • Validate signal-to-noise ratio in multiplexed imaging contexts

  • Develop appropriate image analysis workflows for quantification

When developing these applications, researchers should conduct preliminary experiments to establish the minimum detectable quantity of SPCC663.14c protein, as single-cell techniques often operate at the limits of detection sensitivity. Validation approaches used for other antibodies in single-cell contexts can provide methodological guidance .

What considerations are important when applying the SPCC663.14c antibody in interdisciplinary research contexts?

For effective application of the SPCC663.14c antibody across disciplinary boundaries:

• Evolutionary biology studies:

  • Evaluate cross-reactivity with homologous proteins in related yeast species

  • Develop appropriate controls when comparing across species

  • Consider epitope conservation when interpreting cross-species results

• Systems biology integration:

  • Standardize quantification for integration with other -omics datasets

  • Develop consistent normalization strategies across experimental platforms

  • Validate key nodes in predicted networks using orthogonal methods

• Translational research applications (if human homologs exist):

  • Carefully assess cross-reactivity with human homologs

  • Validate findings in multiple model systems

  • Consider developing separate antibodies targeting conserved versus divergent epitopes

Interdisciplinary applications often require additional validation steps to ensure that methods developed for one discipline maintain their reliability when applied in new contexts. Consulting with experts across relevant fields can help identify potential methodological pitfalls before they impact research outcomes .

What future developments might enhance the utility of antibodies targeting SPCC663.14c?

Anticipated technological advances that could improve SPCC663.14c research:

• Next-generation antibody engineering:

  • Development of recombinant antibodies with improved specificity

  • Generation of single-domain antibodies (nanobodies) for applications requiring smaller probes

  • Creation of bispecific antibodies for simultaneous targeting of SPCC663.14c and interacting partners

• Advanced imaging applications:

  • Super-resolution microscopy-compatible antibody formats

  • Photoswitchable or photoactivatable antibody conjugates

  • Intrabody development for live-cell applications

• Enhanced multiplexing capabilities:

  • Antibody conjugates compatible with highly multiplexed imaging

  • Sequential detection strategies for co-localization studies

  • Integration with spatial transcriptomics for multi-omics analysis

These technological advances will likely build upon existing antibody validation principles while extending the applications possible with SPCC663.14c-targeting reagents. Researchers should stay informed about emerging technologies that may complement traditional antibody-based approaches .

How can researchers contribute to improving SPCC663.14c antibody validation standards?

Practical approaches for advancing antibody validation in the research community:

• Comprehensive reporting standards:

  • Document detailed validation procedures in publications

  • Share negative results and cross-reactivity findings

  • Provide lot-specific validation data when publishing

• Community-based validation resources:

  • Contribute validation data to repositories like Antibodypedia or CiteAb

  • Participate in multi-laboratory validation initiatives

  • Share optimized protocols through platforms like protocols.io

• Integrated validation approaches:

  • Combine orthogonal methods (genetic, proteomic, imaging) in validation

  • Develop quantitative metrics for antibody performance

  • Establish minimum validation requirements for specific applications